Document is current
Any future updates will be listed below
-
Authors
Bowman-Busato, Jacqueline
Schreurs, Lucas https://orcid.org/0009-0007-9608-3830
Halford, Jason C. G.
Yumuk, Volkan
O’Malley, Grace https://orcid.org/0000-0002-2421-3866
Woodward, Euan
De Cock, Diederik
Baker, Jennifer L. https://orcid.org/0000-0002-9649-6615
- License Information
-
More Information
Article History
Received: 30 January 2024
Revised: 30 May 2024
Accepted: 10 June 2024
First Online: 20 June 2024
Competing interests
: JBB has no conflicts of interest related to this work, LS has no conflicts of interests related to this work. JCGH has no conflicts of interest related to this work and declares funding for consultancy and speaking from Novo Nordisk and Boehringer Ingelheim respectively. All monies are paid to the University of Leeds to support research. VY has no conflicts of interest related to this work and declares funding Eli Lilly, for providing single advisor activity and Novo Nordisk, for providing educational sessions or attending advisory boards. GOM has no conflicts of interest related to this work. EW has no conflicts of interest related to this work. DDC has no conflicts of interests related to this work. JLB has no conflicts of interest related to this work, and declares having received consulting fees from Novo Nordisk A/S.
: According to the Free University of Brussels (VUB) regulations where the study was conducted, ethics committee approval was not required for this study.
